Table 4 Factors associated with UAC at the start of treatment in Molecular-targeted drug users (Multivariate Analysis).

From: Predictors of chemotherapy-related unplanned acute care in outpatients receiving oral anticancer drugs

Factor

Adjusted odds ratio

(95% CI)

p-value

Treatment Line

0.53 (0.29–0.97)

0.04*

ALB

1.04 (0.42–2.60)

0.93

GLU

1.00 (0.99–1.01)

0.47

CRE

3.07 (1.14–8.27)

0.03*

Ca

0.85 (0.37–1.94)

0.70

AST

1.02 (0.99–1.04)

0.20

ALT

1.00 (0.98–1.02)

0.94

LDH

0.99 (0.99–1.00)

0.59

CRP

1.12 (0.96–1.31)

0.14

Hb

0.84 (0.70–1.01)

0.07

Plt

1.04 (0.99–1.10)

0.07

WBC

1.01 (0.95–1.06)

0.84

Neut

0.99 (0.93–1.05)

0.73

Mono

1.06 (0.85–1.34)

0.59

  1. Adjusted for all listed covariates. The Hosmer–Lemeshow test yielded a p-value of 0.973, indicating a good model fit, but AUC was 0.681, suggesting limited predictive accuracy. Additionally, the variance inflation factors (VIFs) for all variables were below 10, indicating no evidence of multicollinearity.
  2. Adjusted odds ratios for continuous variables indicate an association with a 1-unit increase.
  3. *: p < 0.05.
  4. UAC: unplanned acute care.
Back to article page